BlackRock, Inc. 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BLACKROCK INC BLK |
9,443,887 11.300% |
605,872 (+6.86%) |
Filing |
| 2023-11-07 3:33 pm Purchase |
2023-10-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BLACKROCK INC BLK |
8,838,015 10.600% |
804,443 (+10.01%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BLACKROCK INC BLK |
8,033,572 9.600% |
2,252,375 (+38.96%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BLACKROCK INC BLK |
5,781,197 7.000% |
5,781,197 (New Position) |
Filing |